Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
58
UPGD Quote, Financials, Valuation and Earnings
Last price:
$75.17
Seasonality move
:
5.42%
Day range:
$75.00 - $75.15
52-week range:
$61.76 - $76.49
Dividend yield:
1.72%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
3K
Avg. volume:
1.3K
1-year change:
6.99%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
UPGD
Invesco Bloomberg Analyst Rating Improvers ETF
|
-- | -- | -- | -- | -- |
|
CZA
Invesco Zacks Mid-Cap ETF
|
-- | -- | -- | -- | -- |
|
EQAL
Invesco Russell 1000 Equal Weight ETF
|
-- | -- | -- | -- | -- |
|
IQSM
NYLI Candriam US Mid Cap Equity ETF
|
-- | -- | -- | -- | -- |
|
JPME
JPMorgan Diversified Return US Mid Cap Equity ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
UPGD
Invesco Bloomberg Analyst Rating Improvers ETF
|
$75.15 | -- | -- | -- | $1.29 | 1.72% | -- |
|
CZA
Invesco Zacks Mid-Cap ETF
|
$112.25 | -- | -- | -- | $1.73 | 1.54% | -- |
|
EQAL
Invesco Russell 1000 Equal Weight ETF
|
$53.26 | -- | -- | -- | $0.25 | 1.77% | -- |
|
IQSM
NYLI Candriam US Mid Cap Equity ETF
|
$35.31 | -- | -- | -- | $0.13 | 1.16% | -- |
|
JPME
JPMorgan Diversified Return US Mid Cap Equity ETF
|
$110.09 | -- | -- | -- | $0.73 | 2% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
UPGD
Invesco Bloomberg Analyst Rating Improvers ETF
|
-- | 0.665 | -- | -- |
|
CZA
Invesco Zacks Mid-Cap ETF
|
-- | 0.706 | -- | -- |
|
EQAL
Invesco Russell 1000 Equal Weight ETF
|
-- | 0.824 | -- | -- |
|
IQSM
NYLI Candriam US Mid Cap Equity ETF
|
-- | 1.045 | -- | -- |
|
JPME
JPMorgan Diversified Return US Mid Cap Equity ETF
|
-- | 0.708 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
UPGD
Invesco Bloomberg Analyst Rating Improvers ETF
|
-- | -- | -- | -- | -- | -- |
|
CZA
Invesco Zacks Mid-Cap ETF
|
-- | -- | -- | -- | -- | -- |
|
EQAL
Invesco Russell 1000 Equal Weight ETF
|
-- | -- | -- | -- | -- | -- |
|
IQSM
NYLI Candriam US Mid Cap Equity ETF
|
-- | -- | -- | -- | -- | -- |
|
JPME
JPMorgan Diversified Return US Mid Cap Equity ETF
|
-- | -- | -- | -- | -- | -- |
Invesco Bloomberg Analyst Rating Improvers ETF vs. Competitors
-
Which has Higher Returns UPGD or CZA?
Invesco Zacks Mid-Cap ETF has a net margin of -- compared to Invesco Bloomberg Analyst Rating Improvers ETF's net margin of --. Invesco Bloomberg Analyst Rating Improvers ETF's return on equity of -- beat Invesco Zacks Mid-Cap ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital UPGDInvesco Bloomberg Analyst Rating Improvers ETF-- -- -- CZAInvesco Zacks Mid-Cap ETF-- -- -- -
What do Analysts Say About UPGD or CZA?
Invesco Bloomberg Analyst Rating Improvers ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Zacks Mid-Cap ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Bloomberg Analyst Rating Improvers ETF has higher upside potential than Invesco Zacks Mid-Cap ETF, analysts believe Invesco Bloomberg Analyst Rating Improvers ETF is more attractive than Invesco Zacks Mid-Cap ETF.
Company Buy Ratings Hold Ratings Sell Ratings UPGDInvesco Bloomberg Analyst Rating Improvers ETF0 0 0 CZAInvesco Zacks Mid-Cap ETF0 0 0 -
Is UPGD or CZA More Risky?
Invesco Bloomberg Analyst Rating Improvers ETF has a beta of 0.944, which suggesting that the stock is 5.64% less volatile than S&P 500. In comparison Invesco Zacks Mid-Cap ETF has a beta of 0.880, suggesting its less volatile than the S&P 500 by 12.032%.
-
Which is a Better Dividend Stock UPGD or CZA?
Invesco Bloomberg Analyst Rating Improvers ETF has a quarterly dividend of $1.29 per share corresponding to a yield of 1.72%. Invesco Zacks Mid-Cap ETF offers a yield of 1.54% to investors and pays a quarterly dividend of $1.73 per share. Invesco Bloomberg Analyst Rating Improvers ETF pays -- of its earnings as a dividend. Invesco Zacks Mid-Cap ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UPGD or CZA?
Invesco Bloomberg Analyst Rating Improvers ETF quarterly revenues are --, which are smaller than Invesco Zacks Mid-Cap ETF quarterly revenues of --. Invesco Bloomberg Analyst Rating Improvers ETF's net income of -- is lower than Invesco Zacks Mid-Cap ETF's net income of --. Notably, Invesco Bloomberg Analyst Rating Improvers ETF's price-to-earnings ratio is -- while Invesco Zacks Mid-Cap ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Bloomberg Analyst Rating Improvers ETF is -- versus -- for Invesco Zacks Mid-Cap ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UPGDInvesco Bloomberg Analyst Rating Improvers ETF-- -- -- -- CZAInvesco Zacks Mid-Cap ETF-- -- -- --
-
Which has Higher Returns UPGD or EQAL?
Invesco Russell 1000 Equal Weight ETF has a net margin of -- compared to Invesco Bloomberg Analyst Rating Improvers ETF's net margin of --. Invesco Bloomberg Analyst Rating Improvers ETF's return on equity of -- beat Invesco Russell 1000 Equal Weight ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital UPGDInvesco Bloomberg Analyst Rating Improvers ETF-- -- -- EQALInvesco Russell 1000 Equal Weight ETF-- -- -- -
What do Analysts Say About UPGD or EQAL?
Invesco Bloomberg Analyst Rating Improvers ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Russell 1000 Equal Weight ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Bloomberg Analyst Rating Improvers ETF has higher upside potential than Invesco Russell 1000 Equal Weight ETF, analysts believe Invesco Bloomberg Analyst Rating Improvers ETF is more attractive than Invesco Russell 1000 Equal Weight ETF.
Company Buy Ratings Hold Ratings Sell Ratings UPGDInvesco Bloomberg Analyst Rating Improvers ETF0 0 0 EQALInvesco Russell 1000 Equal Weight ETF0 0 0 -
Is UPGD or EQAL More Risky?
Invesco Bloomberg Analyst Rating Improvers ETF has a beta of 0.944, which suggesting that the stock is 5.64% less volatile than S&P 500. In comparison Invesco Russell 1000 Equal Weight ETF has a beta of 0.967, suggesting its less volatile than the S&P 500 by 3.336%.
-
Which is a Better Dividend Stock UPGD or EQAL?
Invesco Bloomberg Analyst Rating Improvers ETF has a quarterly dividend of $1.29 per share corresponding to a yield of 1.72%. Invesco Russell 1000 Equal Weight ETF offers a yield of 1.77% to investors and pays a quarterly dividend of $0.25 per share. Invesco Bloomberg Analyst Rating Improvers ETF pays -- of its earnings as a dividend. Invesco Russell 1000 Equal Weight ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UPGD or EQAL?
Invesco Bloomberg Analyst Rating Improvers ETF quarterly revenues are --, which are smaller than Invesco Russell 1000 Equal Weight ETF quarterly revenues of --. Invesco Bloomberg Analyst Rating Improvers ETF's net income of -- is lower than Invesco Russell 1000 Equal Weight ETF's net income of --. Notably, Invesco Bloomberg Analyst Rating Improvers ETF's price-to-earnings ratio is -- while Invesco Russell 1000 Equal Weight ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Bloomberg Analyst Rating Improvers ETF is -- versus -- for Invesco Russell 1000 Equal Weight ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UPGDInvesco Bloomberg Analyst Rating Improvers ETF-- -- -- -- EQALInvesco Russell 1000 Equal Weight ETF-- -- -- --
-
Which has Higher Returns UPGD or IQSM?
NYLI Candriam US Mid Cap Equity ETF has a net margin of -- compared to Invesco Bloomberg Analyst Rating Improvers ETF's net margin of --. Invesco Bloomberg Analyst Rating Improvers ETF's return on equity of -- beat NYLI Candriam US Mid Cap Equity ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital UPGDInvesco Bloomberg Analyst Rating Improvers ETF-- -- -- IQSMNYLI Candriam US Mid Cap Equity ETF-- -- -- -
What do Analysts Say About UPGD or IQSM?
Invesco Bloomberg Analyst Rating Improvers ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand NYLI Candriam US Mid Cap Equity ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Bloomberg Analyst Rating Improvers ETF has higher upside potential than NYLI Candriam US Mid Cap Equity ETF, analysts believe Invesco Bloomberg Analyst Rating Improvers ETF is more attractive than NYLI Candriam US Mid Cap Equity ETF.
Company Buy Ratings Hold Ratings Sell Ratings UPGDInvesco Bloomberg Analyst Rating Improvers ETF0 0 0 IQSMNYLI Candriam US Mid Cap Equity ETF0 0 0 -
Is UPGD or IQSM More Risky?
Invesco Bloomberg Analyst Rating Improvers ETF has a beta of 0.944, which suggesting that the stock is 5.64% less volatile than S&P 500. In comparison NYLI Candriam US Mid Cap Equity ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock UPGD or IQSM?
Invesco Bloomberg Analyst Rating Improvers ETF has a quarterly dividend of $1.29 per share corresponding to a yield of 1.72%. NYLI Candriam US Mid Cap Equity ETF offers a yield of 1.16% to investors and pays a quarterly dividend of $0.13 per share. Invesco Bloomberg Analyst Rating Improvers ETF pays -- of its earnings as a dividend. NYLI Candriam US Mid Cap Equity ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UPGD or IQSM?
Invesco Bloomberg Analyst Rating Improvers ETF quarterly revenues are --, which are smaller than NYLI Candriam US Mid Cap Equity ETF quarterly revenues of --. Invesco Bloomberg Analyst Rating Improvers ETF's net income of -- is lower than NYLI Candriam US Mid Cap Equity ETF's net income of --. Notably, Invesco Bloomberg Analyst Rating Improvers ETF's price-to-earnings ratio is -- while NYLI Candriam US Mid Cap Equity ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Bloomberg Analyst Rating Improvers ETF is -- versus -- for NYLI Candriam US Mid Cap Equity ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UPGDInvesco Bloomberg Analyst Rating Improvers ETF-- -- -- -- IQSMNYLI Candriam US Mid Cap Equity ETF-- -- -- --
-
Which has Higher Returns UPGD or JPME?
JPMorgan Diversified Return US Mid Cap Equity ETF has a net margin of -- compared to Invesco Bloomberg Analyst Rating Improvers ETF's net margin of --. Invesco Bloomberg Analyst Rating Improvers ETF's return on equity of -- beat JPMorgan Diversified Return US Mid Cap Equity ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital UPGDInvesco Bloomberg Analyst Rating Improvers ETF-- -- -- JPMEJPMorgan Diversified Return US Mid Cap Equity ETF-- -- -- -
What do Analysts Say About UPGD or JPME?
Invesco Bloomberg Analyst Rating Improvers ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand JPMorgan Diversified Return US Mid Cap Equity ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Bloomberg Analyst Rating Improvers ETF has higher upside potential than JPMorgan Diversified Return US Mid Cap Equity ETF, analysts believe Invesco Bloomberg Analyst Rating Improvers ETF is more attractive than JPMorgan Diversified Return US Mid Cap Equity ETF.
Company Buy Ratings Hold Ratings Sell Ratings UPGDInvesco Bloomberg Analyst Rating Improvers ETF0 0 0 JPMEJPMorgan Diversified Return US Mid Cap Equity ETF0 0 0 -
Is UPGD or JPME More Risky?
Invesco Bloomberg Analyst Rating Improvers ETF has a beta of 0.944, which suggesting that the stock is 5.64% less volatile than S&P 500. In comparison JPMorgan Diversified Return US Mid Cap Equity ETF has a beta of 0.946, suggesting its less volatile than the S&P 500 by 5.437%.
-
Which is a Better Dividend Stock UPGD or JPME?
Invesco Bloomberg Analyst Rating Improvers ETF has a quarterly dividend of $1.29 per share corresponding to a yield of 1.72%. JPMorgan Diversified Return US Mid Cap Equity ETF offers a yield of 2% to investors and pays a quarterly dividend of $0.73 per share. Invesco Bloomberg Analyst Rating Improvers ETF pays -- of its earnings as a dividend. JPMorgan Diversified Return US Mid Cap Equity ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UPGD or JPME?
Invesco Bloomberg Analyst Rating Improvers ETF quarterly revenues are --, which are smaller than JPMorgan Diversified Return US Mid Cap Equity ETF quarterly revenues of --. Invesco Bloomberg Analyst Rating Improvers ETF's net income of -- is lower than JPMorgan Diversified Return US Mid Cap Equity ETF's net income of --. Notably, Invesco Bloomberg Analyst Rating Improvers ETF's price-to-earnings ratio is -- while JPMorgan Diversified Return US Mid Cap Equity ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Bloomberg Analyst Rating Improvers ETF is -- versus -- for JPMorgan Diversified Return US Mid Cap Equity ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UPGDInvesco Bloomberg Analyst Rating Improvers ETF-- -- -- -- JPMEJPMorgan Diversified Return US Mid Cap Equity ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
